GlassScriptPhysician profile
Erin P Garner
NPI 1275863029
$51,560.90
in general payments reported to CMS, 2019-2025
22 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $66.30 · 2021: $14K · 2022: $22K · 2023: $15K · 2024: $323 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $1,780 · Travel and Lodging: $1,506 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,085.00 |
| Food and Beverage | $1,779.97 |
| Travel and Lodging | $1,505.94 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $49,773.55 | 2021-2024 | Da Vinci Surgical System |
| Abbvie INC. | $517.22 | 2019-2024 | |
| Amgen INC. | $304.85 | 2019-2024 | Evenity, Prolia |
| Astellas Pharma US INC | $219.95 | 2021-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $159.53 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $88.15 | 2021-2025 | |
| Biogen, INC. | $86.98 | 2024-2025 | Zurzuvae, Vumerity |
| Evofem Biosciences, INC. | $65.05 | 2021-2022 | |
| Pfizer INC. | $52.47 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.42 | 2019 | |
| Exeltis, USA INC. | $35.70 | 2021-2023 | Slynd |
| Shield Therapeutics INC | $33.74 | 2025 | |
| Novo Nordisk INC | $29.28 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.00 | 2022 | |
| Coopersurgical, INC. | $25.00 | 2023 | Summit Doppler |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.02 | 2022 | |
| Hologic Sales and Service, LLC | $15.81 | 2020 | |
| Exact Sciences Corporation | $15.42 | 2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $15.27 | 2021 | |
| Minerva Surgical, INC | $14.09 | 2023 | |
| Idorsia Pharmaceuticals US INC | $13.95 | 2024 | Quviviq |
| Organon LLC | $10.45 | 2025 | Nuvaring, Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Garner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.